Aref Al-Kali, M.D., stands as a paragon of medical expertise in Hematology and Oncology, with a multifaceted career that spans across clinical trials, education, and research. Fluent in Arabic and English, Dr. Al-Kali's international education commenced at the University of Damascus Medical School, followed by comprehensive training at esteemed institutions including Oklahoma University and the University of Texas M.D. Anderson Cancer Center.
Currently stationed at Rochester, Minnesota, Dr. Al-Kali's remarkable contributions as a Research Chair at Mayo Clinic Cancer Center and active roles in executive committees reflect his leadership in the field. His profound impact on medicine is underscored by his treatment of complex conditions such as acute myeloid leukemia and myelodysplastic syndromes. Dr. Al-Kali's dedication to advancing healthcare is further exemplified by his recognition for Excellence in Education within the Internal Medicine Residency Program, affirming his commitment to shaping future medical pioneers.
He works in the hematology department.
Dr. Aref works at - Mayo Clinic Rochester.
Dr. Aref specializes in diseases and treatments such as myelodysplastic syndromes, acute myeloid leukemia, chronic myelomonocytic leukemia and myeloproliferative neoplasms, acute lymphoblastic leukemia.